Identification of murine T-cell epitopes on low-molecular-mass secretory proteins (CFP11, CFP17, and TB18.5) of Mycobacterium tuberculosis

Vaccine

Volumn 28, Issue 29, 2010, Pages 4616-4625

  Eweda, Ghada ^a   Suzuki, Daisuke ^a   Nagata, Toshi ^a   Tsujimura, Kunio ^a   Koide, Yukio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Low molecular mass proteins; Mycobacterium tuberculosis; T cell epitopes

Indexed keywords

BACTERIAL PROTEIN; CULTURE FLUID PROTEIN 11; CULTURE FLUID PROTEIN 17; EPITOPE; GAMMA INTERFERON; PROTEIN TB18.5; UNCLASSIFIED DRUG;

ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; INBRED STRAIN; MOLECULAR WEIGHT; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SPLEEN CELL; TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; SPLEEN;

EID: 77953122218     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.079     Document Type: Article

References (43)

1. World Health Organization. WHO Report 2009 Global tuberculosis control: epidemiology, strategy, financing. Geneva. http://www.who.int/tb/publications/global_report/2009/pdf/full_report.pdf; 2009 [online].
2. Andersen P., and Doherty T.M. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3 (2005) 656-662
3. Bloom B.R., and Fine P.E.M. The BCG experience: implications for future vaccines against tuberculosis. Tuberculosis: pathogenesis, protection, and control (1994), ASM Press, Washington, DC p. 531-57
4. Fine P.E.M. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346 (1995) 1339-1345
5. Sterne J.A.C., Rodrigues L.C., and Guedes I.N. Does the efficacy of BCG decline with time since vaccination?. Int J Tuberc Lung Dis 2 (1998) 200-207
6. Kaufmann S.H.E., Baumann S., and Nasser Eddine A. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis. Int J Tuberc Lung Dis 10 (2006) 1068-1079
7. Cooper A.M. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27 (2009) 393-422
8. Kaufmann S.H.E. How can immunology contribute to the control of tuberculosis?. Nat Rev Immunol 1 (2001) 20-30
9. + T cells in mycobacterial infections. Immunol Cell Biol 78 (2000) 325-333
10. Kaufumann S.H.E., and Flynn J.L. CD8 T cells in tuberculosis. In: Cole S.T., Eisenach K.D., McMurray D.N., and Jacobs Jr. W.R. (Eds). Tuberculosis and the tubercle bacillus (2005), ASM Press, Washington, DC 465-474
11. Sable S.B., Karlra M., Verma I., and Khuller G.K. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity. Clin Immunol 122 (2007) 239-251
12. Cole S.T., Brosch R., Parkhill J., Garunier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
13. Orme I.A. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with killed mycobacterial vaccines. Infect Immun 56 (1988) 3310-3312
14. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 62 (1994) 2536-2544
15. Horwitz M.A., Lee B.W.E., Dillon B.J., and Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 92 (1995) 1530-1534
16. Roberts A.D., Sonnenberg M.G., Ordway D.J., Furney S.K., Brennan P.J., Belisle J.T., et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85 (1995) 502-508
17. Boesen H., Jensen B.N., Wilcke T., and Andersen P. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 63 (1995) 1491-1497
18. Demissie A., Ravn P., Olobo J., Doherty T.M., Eguale T., Geletu M., et al. T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infect Immun 67 (1999) 5967-5971
19. Andersen P., Munk M.E., Pollock J.M., and Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet 356 (2000) 1099-1104
20. Weldingh K., Rosenkrands I., Jacobsen S., Rasmussen P.B., Elhay M.J., and Andersen P. Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun 66 (1998) 3492-3500
21. Weldingh K., and Andersen P. Immunological evaluation of novel Mycobacterium tuberculosis culture filtrate proteins. FEMS Immunol Med Microbiol 23 (1999) 159-164
22. Lim J.H., Kim H.J., Lee K.S., Jo E.K., Song C.H., Jung S.B., et al. Identification of the new T-cell-stimulating antigens from Mycobacterium tuberculosis culture filtrate. FEMS Microbiol Lett 232 (2004) 51-59
23. Sable S.B., Kumar R., Kalra M., Verma I., Khuller G.K., Dobos K., et al. Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis. Infect Immun 73 (2005) 3547-3558
24. Belisle J.T., Braunstein M., Rosenkrands I., and Andersen P. The proteome of Mycobacterium tuberculosis. In: Cole S.T., Eisenach K.D., McMurray D.N., and Jacobs Jr. W.R. (Eds). Tuberculosis and the tubercle bacillus (2005), ASM Press, Washington, DC 235-260
25. Bu L., and Brooks III C.L. De novo prediction of the structures of M. Tuberculosis membrane proteins. J Am Chem Soc 130 (2008) 5384-5385
26. Yoshida A., Nagata T., Uchijima M., Higashi T., and Koide Y. Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine 18 (2000) 1725-1729
27. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun 66 (1998) 1527-1533
28. D'Souza S., Rosseels V., Romano M., Tanghe A., Denis O., Jurion F., et al. Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect Immun 71 (2003) 483-493
29. Aoshi T., Nagata T., Suzuki M., Uchijima M., Hashimoto D., Rafiei A., et al. Identification of an HLA-A*0201-restricted T-cell epitope on MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis by MPT51 overlapping peptide screening. Infect Immun 76 (2008) 1565-1571
30. b-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis. Infect Immun 72 (2004) 3829-3837
31. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152 (1994) 163-175
32. Rammensee H.-G., Bachmann J., Emmerich N.P.N., Bachor O.A., and Sevanović S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50 (1999) 213-219
33. Reche P.A., Glutting J.-P., Zhang H., and Reinherz E.L. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 56 (2004) 405-419
34. Ljunggren H.-G., and Kärre K. Host resistance directed selectively against H-2-deficient lymphoma variants. J Exp Med 162 (1985) 1745-1759
35. Ljunggren H.-G., Stam N.J., Öhlén C., Neefjes J.J., Höglund P., Heemels M.-T., et al. Empty MHC class I molecules come out in the cold. Nature 346 (1990) 476-480
36. Margulies D.H., Natarajan K., Rossjohn J., and McClusky J. Major histocompatibility complex (MHC) molecules: structure, function, and genetics. In: Paul W.E. (Ed). Fundamental immunology. 6th ed. (2008), Lippincott Williams & Wilkins Publishers, Philadelphia 570-613
37. Mathis D.J., Benoist C., Williams II V.E., Kanter M., and McDevitt H.O. Several mechanisms can account for defective Eα gene expression in different mouse haplotypes. Proc Natl Acad Sci U S A 80 (1983) 273-277
38. Ellner J.J., Hirsch C.S., and Whalen C.C. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis 30 Suppl. 3 (2000) S279-S282
39. d-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals. Eur J Immunol 30 (2000) 3338-3346
40. Date Y., Kimura A., Kato H., and Sasazuki T. DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens 47 (1996) 93-101
41. Nakano H., Nagata T., Suda T., Tanaka T., Aoshi T., Uchijima M., et al. Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A. Infect Immun 24 (2006) 2110-2119
42. Fonseca D.P.A.J., Benaissa-Trouw B., van Engelen M., Kraaijeveld C.A., Snippe H., and Verheul A.F.M. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein. Infect Immun 69 (2001) 4839-4845
43. Gao H., Yue Y., Hu L., Xu W., and Xiong S. A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge. Vaccine 27 (2009) 5313-5319